Innocoll AG Secures EUR 25 Million Loan Commitment From European Investment Bank (EIB)
March 30, 2015 07:00 ET
|
Innocoll Holdings plc
EIB's InnovFin Financing Supports Innovative Companies under Horizon 2020
Financing to Support Manufacturing Facility Expansion and Development of Lead Product Candidates
ATHLONE, Ireland, March...
Innocoll AG Announces Fourth Quarter and Full Year 2014 Financial and Operating Results
March 19, 2015 07:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, March 19, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...
Innocoll AG Appoints James Tursi, M.D., as Chief Medical Officer
March 18, 2015 07:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, March 18, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) today announced that James Tursi, M.D., has been appointed chief medical officer. Dr. Tursi will be responsible for...
Innocoll to Report Fourth Quarter and Full Year 2014 Financial Results and Host Webcast and Conference Call on March 19, 2015
March 13, 2015 16:15 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, March 13, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll AG Appoints Tony Zook as Chief Executive Officer as Company Progresses Toward Becoming a Fully-Integrated Commercial Company
December 08, 2014 07:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) today announced that Tony Zook, formerly executive vice president, Global Commercial Operations, at AstraZeneca, has been...
Innocoll AG Announces Third Quarter 2014 Financial and Operating Results
November 13, 2014 08:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...
Innocoll to Report Third Quarter 2014 Financial Results and Host Webcast and Conference Call on November 13, 2014
November 06, 2014 16:05 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll AG Proposes Changes to Supervisory Board and Stock Option Plan
October 22, 2014 16:30 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...
Innocoll AG Announces Closing of Initial Public Offering
July 30, 2014 17:39 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, July 30, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll AG Announces Pricing of Initial Public Offering
July 25, 2014 07:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, July 25, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...